Related Experiment Video
Updated: Aug 10, 2026
14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Developmental bronchopulmonary disease in adults: practical clinical considerations
Canadian Journal of Surgery. Journal Canadien De Chirurgie
|January 1, 1981
Summary
Congenital bronchovascular anomalies, including bronchogenic cysts and arteriovenous malformations, often require surgical intervention. Early diagnosis and treatment are crucial for managing these developmental defects in both children and adults.
Area of Science:
- Pulmonology
- Thoracic Surgery
- Pediatric Surgery
Background:
- Developmental abnormalities of the tracheobronchial tree and its vascular components present in pediatric and adult patients.
- These anomalies manifest as pure bronchial, pure vascular, or combined defects, reflecting failures in bronchovascular development.
- Common adult presentations include bronchogenic cysts (bronchial), arteriovenous malformations (vascular), and sequestrations (mixed).
Purpose of the Study:
- To review the clinical syndromes associated with congenital bronchovascular anomalies.
- To analyze the diagnostic and therapeutic considerations for these anomalies.
- To evaluate the necessity of surgical intervention for various bronchovascular defects.
Main Methods:
- Retrospective review of patients treated for bronchogenic cysts, sequestrations, and parenchymal aneurysms.
- Analysis of diagnostic findings and treatment outcomes.
- Evaluation of surgical intervention efficacy.
Main Results:
- Between 1958 and 1978, 32 bronchogenic cysts, 14 sequestrations, and 18 parenchymal aneurysms were treated.
- Surgical intervention was deemed warranted in the majority of cases.
- The study highlights common presentations and effective management strategies.
Conclusions:
- Congenital bronchovascular anomalies represent a spectrum of developmental failures.
- Surgical management is frequently indicated for these conditions.
- Prompt diagnosis and intervention improve patient outcomes.
Related Concept Videos
01:20COPD: Pathogenesis and Clinical Features
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:26COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:29Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...